- Home
- ARQT vs BWIN Comparison
ARQT vs BWIN Comparison
Compare ARQT & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- BWIN
- Stock Information
- Founded
- ARQT 2016
- BWIN 2011
- Country
- ARQT United States
- BWIN United States
- Employees
- ARQT N/A
- BWIN N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- BWIN Specialty Insurers
- Sector
- ARQT Health Care
- BWIN Finance
- Exchange
- ARQT Nasdaq
- BWIN Nasdaq
- Market Cap
- ARQT 2.1B
- BWIN 1.7B
- IPO Year
- ARQT 2020
- BWIN 2019
- Fundamental
- Price
- ARQT $24.38
- BWIN $25.32
- Analyst Decision
- ARQT Strong Buy
- BWIN Hold
- Analyst Count
- ARQT 7
- BWIN 7
- Target Price
- ARQT $22.17
- BWIN $38.29
- AVG Volume (30 Days)
- ARQT 2.5M
- BWIN 1.0M
- Earning Date
- ARQT 10-28-2025
- BWIN 11-04-2025
- Dividend Yield
- ARQT N/A
- BWIN N/A
- EPS Growth
- ARQT N/A
- BWIN N/A
- EPS
- ARQT N/A
- BWIN N/A
- Revenue
- ARQT $317,929,000.00
- BWIN $1,487,497,000.00
- Revenue This Year
- ARQT $85.27
- BWIN $10.87
- Revenue Next Year
- ARQT $30.70
- BWIN $12.60
- P/E Ratio
- ARQT N/A
- BWIN N/A
- Revenue Growth
- ARQT 129.21
- BWIN 10.69
- 52 Week Low
- ARQT $8.45
- BWIN $21.26
- 52 Week High
- ARQT $27.08
- BWIN $50.46
- Technical
- Relative Strength Index (RSI)
- ARQT 64.85
- BWIN 50.37
- Support Level
- ARQT $19.60
- BWIN $21.26
- Resistance Level
- ARQT $27.08
- BWIN $24.58
- Average True Range (ATR)
- ARQT 1.25
- BWIN 1.07
- MACD
- ARQT 0.21
- BWIN 0.28
- Stochastic Oscillator
- ARQT 63.91
- BWIN 93.55
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About BWIN The Baldwin Insurance Group Inc. Class A Common Stock
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.